Scholarly Index
David I. Quinn
AbbVie (United States); 27,619 total citations; 638 total publications; best world rank #233
AbbVie (United States)
27,619Total citations
638Total publications
76H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Prostate Cancer Treatment and Research | Lifetime | 264 | US 155 | 99.17 |
| Renal cell carcinoma treatment | Lifetime | 233 | US 140 | 98.82 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 511 | US 262 | 98.85 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 286 | US 158 | 98.79 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 546 | US 225 | 97.30 |
| Cancer, Lipids, and Metabolism | Lifetime | 801 | US 373 | 97.22 |
| Urinary and Genital Oncology Studies | Lifetime | 401 | US 194 | 97.33 |
| Renal and related cancers | Lifetime | 870 | US 422 | 96.37 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 236 | US 76 | 97.08 |
| Renal cell carcinoma treatment | 2021-2025 | 399 | US 146 | 93.95 |
| Prostate Cancer Treatment and Research | 2021-2025 | 622 | US 220 | 94.69 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 756 | US 182 | 87.72 |
| Renal and related cancers | 2021-2025 | 882 | US 317 | 81.83 |
| Urinary and Genital Oncology Studies | 2021-2025 | 780 | US 228 | 83.33 |
| Axon Guidance and Neuronal Signaling | 2021-2025 | 742 | US 246 | 25.30 |